These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 30906642)

  • 21. In depth analysis of kinase cross screening data to identify chemical starting points for inhibition of the Nek family of kinases.
    Wells CI; Kapadia NR; Couñago RM; Drewry DH
    Medchemcomm; 2018 Jan; 9(1):44-66. PubMed ID: 30108900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Leveraging Structural Diversity and Allosteric Regulatory Mechanisms of Protein Kinases in the Discovery of Small Molecule Inhibitors.
    Verkhivker GM
    Curr Med Chem; 2017; 24(42):4838-4872. PubMed ID: 27719654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of a PEAK1/ZEB1 signaling axis during TGFβ/fibronectin-induced EMT in breast cancer.
    Agajanian M; Runa F; Kelber JA
    Biochem Biophys Res Commun; 2015 Sep; 465(3):606-12. PubMed ID: 26297948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two nucleus-localized CDK-like kinases with crucial roles for malaria parasite erythrocytic replication are involved in phosphorylation of splicing factor.
    Agarwal S; Kern S; Halbert J; Przyborski JM; Baumeister S; Dandekar T; Doerig C; Pradel G
    J Cell Biochem; 2011 May; 112(5):1295-310. PubMed ID: 21312235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The ErbB/HER receptor protein-tyrosine kinases and cancer.
    Roskoski R
    Biochem Biophys Res Commun; 2004 Jun; 319(1):1-11. PubMed ID: 15158434
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Presence and utility of intrinsically disordered regions in kinases.
    Kathiriya JJ; Pathak RR; Clayman E; Xue B; Uversky VN; Davé V
    Mol Biosyst; 2014 Nov; 10(11):2876-88. PubMed ID: 25099472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Orange is the new black: Kinases are the new master regulators of tumor suppression.
    An E; Brognard J
    IUBMB Life; 2019 Jun; 71(6):738-748. PubMed ID: 30548122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on the regulation of the mitochondrial alpha-ketoacid dehydrogenase complexes and their kinases.
    Harris RA; Hawes JW; Popov KM; Zhao Y; Shimomura Y; Sato J; Jaskiewicz J; Hurley TD
    Adv Enzyme Regul; 1997; 37():271-93. PubMed ID: 9381974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploring sequence-structure relationships in the tyrosine kinome space: functional classification of the binding specificity mechanisms for cancer therapeutics.
    Verkhivker GM
    Bioinformatics; 2007 Aug; 23(15):1919-26. PubMed ID: 17537753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PRKCQ promotes oncogenic growth and anoikis resistance of a subset of triple-negative breast cancer cells.
    Byerly J; Halstead-Nussloch G; Ito K; Katsyv I; Irie HY
    Breast Cancer Res; 2016 Sep; 18(1):95. PubMed ID: 27663795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of small adaptor proteins in the control of oncogenic signalingr driven by tyrosine kinases in human cancer.
    Naudin C; Chevalier C; Roche S
    Oncotarget; 2016 Mar; 7(10):11033-55. PubMed ID: 26788993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting oncogenic Raf protein-serine/threonine kinases in human cancers.
    Roskoski R
    Pharmacol Res; 2018 Sep; 135():239-258. PubMed ID: 30118796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative studies of a new subfamily of human Ste20-like kinases: homodimerization, subcellular localization, and selective activation of MKK3 and p38.
    Yustein JT; Xia L; Kahlenburg JM; Robinson D; Templeton D; Kung HJ
    Oncogene; 2003 Sep; 22(40):6129-41. PubMed ID: 13679851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural and functional diversity in the activity and regulation of DAPK-related protein kinases.
    Temmerman K; Simon B; Wilmanns M
    FEBS J; 2013 Nov; 280(21):5533-50. PubMed ID: 23745726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 3'-phosphoinositide-dependent kinase-1 (PDK-1) in PI 3-kinase signaling.
    Storz P; Toker A
    Front Biosci; 2002 Apr; 7():d886-902. PubMed ID: 11897568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integrative analysis of high-throughput RNAi screen data identifies the FER and CRKL tyrosine kinases as new regulators of the mitogenic ERK-dependent pathways in transformed cells.
    Nizard P; Ezan F; Bonnier D; Le Meur N; Langouët S; Baffet G; Arlot-Bonnemains Y; Théret N
    BMC Genomics; 2014 Dec; 15(1):1169. PubMed ID: 25540073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heterodimerization and functional interaction between EGF receptor family members: a new signaling paradigm with implications for breast cancer research.
    Earp HS; Dawson TL; Li X; Yu H
    Breast Cancer Res Treat; 1995 Jul; 35(1):115-32. PubMed ID: 7612898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Src family tyrosine kinases are activated by Flt3 and are involved in the proliferative effects of leukemia-associated Flt3 mutations.
    Robinson LJ; Xue J; Corey SJ
    Exp Hematol; 2005 Apr; 33(4):469-79. PubMed ID: 15781338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The MAP3K7-mTOR Axis Promotes the Proliferation and Malignancy of Hepatocellular Carcinoma Cells.
    Cheng JS; Tsai WL; Liu PF; Goan YG; Lin CW; Tseng HH; Lee CH; Shu CW
    Front Oncol; 2019; 9():474. PubMed ID: 31214512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of a cytoskeleton-associated kinase PEAK1 and E-cadherin in gastric cancer.
    Guo Q; Qin W; Li B; Yang H; Guan J; Liu Z; Li S
    Pathol Res Pract; 2014 Dec; 210(12):793-8. PubMed ID: 25445115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.